Rock Springs Capital Management LP Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$4.3B
Holdings
136
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (136 positions)
| Stock | Value |
|---|---|
NKTXNKARTA INC | $7.8M |
—PARATEK PHARMACEUTICALS INC | $7.6M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $7.5M |
EPIEURESSA PHARMA INC | $7.3M |
SPRBSPRUCE BIOSCIENCES INC | $7.2M |
—ATHIRA PHARMA INC | $7.2M |
DSGNDESIGN THERAPEUTICS INC | $7.2M |
—PHASEBIO PHARMACEUTICALS INC | $6.7M |
DAWNDAY ONE BIOPHARMACEUTICALS I | $6.4M |
FATEFATE THERAPEUTICS INC | $6.4M |
APLTAPPLIED THERAPEUTICS INC | $6.3M |
RYTMRHYTHM PHARMACEUTICALS INC | $6.3M |
—KINNATE BIOPHARMA INC | $6.0M |
INZYINOZYME PHARMA INC | $5.9M |
CGENCOMPUGEN LTD | $5.5M |
—THESEUS PHARMACEUTICALS INC | $5.5M |
—GAMIDA CELL LTD | $5.5M |
PRLDPRELUDE THERAPEUTICS INC | $4.6M |
EDAEDAP TMS S A | $4.6M |
OVASUSDTEMPEST THERAPEUTICS INC | $4.3M |
—FUSION PHARMACEUTICALS INC | $4.0M |
—F-STAR THERAPEUTICS INC | $3.8M |
TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | $3.6M |
—ACELRX PHARMACEUTICALS INC | $3.5M |
—BCLS ACQUISITION CORP | $3.0M |
STTKSHATTUCK LABS INC | $2.7M |
—JIYA ACQUISITION CORP | $2.0M |
PSTXUSDPOSEIDA THERAPEUTICS INC | $2.0M |
—IMARA INC | $1.9M |
—RADIUS HEALTH INC | $1.5M |
—THERAVANCE BIOPHARMA INC | $1.5M |
BCELATRECA INC | $1.4M |
NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC | $1.3M |
—PACIRA BIOSCIENCES INC | $1.0M |
NVRO 2.75 04/01/25NEVRO CORP | $556K |
NUVB/WSNUVATION BIO INC | $253K |
PreviousPage 2 of 2